These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 37950840

  • 1. Synergistic effect of the verapamil and amphotericin B against Cryptococcus neoformans.
    Pereira TC, do Carmo PHF, de Menezes RT, de Oliveira HC, de Oliveira LD, Junqueira JC, Scorzoni L.
    Folia Microbiol (Praha); 2023 Dec; 68(6):999-1004. PubMed ID: 37950840
    [Abstract] [Full Text] [Related]

  • 2. Adaptation to Fluconazole via Aneuploidy Enables Cross-Adaptation to Amphotericin B and Flucytosine in Cryptococcus neoformans.
    Yang F, Gritsenko V, Lu H, Zhen C, Gao L, Berman J, Jiang YY.
    Microbiol Spectr; 2021 Oct 31; 9(2):e0072321. PubMed ID: 34585947
    [Abstract] [Full Text] [Related]

  • 3. Synergistic effect of pyrvinium pamoate and posaconazole against Cryptococcus neoformans in vitro and in vivo.
    Li Y, Li S, Chen M, Xiao J, Fang H.
    Front Cell Infect Microbiol; 2022 Oct 31; 12():1074903. PubMed ID: 36569209
    [Abstract] [Full Text] [Related]

  • 4. Identification of Off-Patent Drugs That Show Synergism with Amphotericin B or That Present Antifungal Action against Cryptococcus neoformans and Candida spp.
    Rossi SA, de Oliveira HC, Agreda-Mellon D, Lucio J, Mendes-Giannini MJS, García-Cambero JP, Zaragoza O.
    Antimicrob Agents Chemother; 2020 Mar 24; 64(4):. PubMed ID: 31988099
    [Abstract] [Full Text] [Related]

  • 5. Efficacy of amphotericin B in combination with flucytosine against flucytosine-susceptible or flucytosine-resistant isolates of Cryptococcus neoformans during disseminated murine cryptococcosis.
    Schwarz P, Dromer F, Lortholary O, Dannaoui E.
    Antimicrob Agents Chemother; 2006 Jan 24; 50(1):113-20. PubMed ID: 16377675
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of antifungal combination against Cryptococcus spp.
    Reichert-Lima F, Busso-Lopes AF, Lyra L, Peron IH, Taguchi H, Mikami Y, Kamei K, Moretti ML, Schreiber AZ.
    Mycoses; 2016 Sep 24; 59(9):585-93. PubMed ID: 27135278
    [Abstract] [Full Text] [Related]

  • 7. Analysis of the relationship between drug susceptibility of Cryptococcus neoformans isolates and mortality in HIV-negative cryptococcal meningitis.
    Su Z, Wei H, Liu J, Li C, Xu Z, Yuan D, Dai K, Peng F, Jiang Y.
    J Glob Antimicrob Resist; 2024 Mar 24; 36():167-174. PubMed ID: 38141953
    [Abstract] [Full Text] [Related]

  • 8. In vitro susceptibility studies of Cryptococcus neoformans isolated from patients with no clinical response to amphotericin B therapy.
    Rodero L, Córdoba S, Cahn P, Hochenfellner F, Davel G, Canteros C, Kaufman S, Guelfand L.
    J Antimicrob Chemother; 2000 Feb 24; 45(2):239-42. PubMed ID: 10660509
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interactions between antifungals and everolimus against Cryptococcus neoformans.
    Liang P, Song J, Liu Q.
    Front Cell Infect Microbiol; 2023 Feb 24; 13():1131641. PubMed ID: 37026056
    [Abstract] [Full Text] [Related]

  • 13. In vitro interaction of antifungal and antibacterial drugs against Cryptococcus neoformans var. grubii before and after capsular induction.
    Rossato L, Loreto ÉS, Venturini TP, Azevedo MI, Weiblen C, Botton SA, Santurio JM, Alves SH.
    Med Mycol; 2015 Nov 24; 53(8):885-9. PubMed ID: 26333356
    [Abstract] [Full Text] [Related]

  • 14. Efficacy of Oral Encochleated Amphotericin B in a Mouse Model of Cryptococcal Meningoencephalitis.
    Lu R, Hollingsworth C, Qiu J, Wang A, Hughes E, Xin X, Konrath KM, Elsegeiny W, Park YD, Atakulu L, Craft JC, Tramont EC, Mannino R, Williamson PR.
    mBio; 2019 May 28; 10(3):. PubMed ID: 31138748
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. In vitro synergistic effect of minocycline combined with antifungals against Cryptococcus neoformans.
    Tan L, Shi H, Chen M, Wang Z, Yao Z, Sun Y.
    J Mycol Med; 2022 Mar 28; 32(1):101227. PubMed ID: 34800920
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.